SC
Sinopharm Capital
Private EquityActiveSinopharm Capital is a private equity arm of China National Pharmaceutical Group Corporation.
Shanghai, ChinaFounded 2013
21
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Sinopharm Capital.
Investment Thesis & Strategy
Sinopharm Capital, as a private equity firm, invests in various stages of venture capital, fintech, and healthcare companies, leveraging its parent company's resources and network within the Chinese market.
Investment Activity
Deals per year over the last 9 years
1
20100
20110
20121
20131
20142
20152
20162
20171
2018Portfolio Companies
Selected investments from their portfolio of 21 companies
J
Jiangsu Hengrui Medicine
Biotech · Growth, 2018
L
Lepu Medical
Healthcare · Growth, 2017
S
Sino Biopharmaceutical
Biotech · Growth, 2017
C
CSPC Pharmaceutical Group
Biotech · Growth, 2016
C
China Resources Pharmaceutical Group
Healthcare · Growth, 2016
W
Wuxi Biologics
Biotech · Growth, 2015
H
Humanwell Healthcare
Healthcare · Growth, 2015
B
BeiGene
Biotech · Growth, 2014
3
3SBio
Biotech · Growth, 2013
S
Shanghai Pharmaceuticals Holding
Healthcare · Growth, 2010
Frequently Asked Questions
Sinopharm Capital focuses on Series B, Series C+ stage investments.